As part of the CannaSyn project, the production of cannabigerol (CBG), a potentially versatile ingredient in hemp and Cannabis plant brought to…
Read more
The Ministry of Economic Affairs and Climate Protection is now funding eleven projects that have applied through the state competition ZukunftBIO.NRW…
The combination of Taros’ small molecule contract research and manufacturing capabilities with Welab’s longstanding expertise with drug discovery projects in a cutting-edge R&D environment will support clients in getting their end-to-end discovery and development programs delivered.
High-ranking visit to the global chemical research and development service provider Taros Chemicals at the BiomedizinZentrumDortmund at the end of 2022.
Which challenges do entrepreneurs face when setting up and establishing a CRO in Europe or Asia? This essential question will be answered by our CEO Dr. Dimitrios Tzalis in the Life Science Get2Gether (LSG2G) Podcast hosted by Christian Soschner.
CARDIOMYO, the European consortium project led by ZeClinics and its partners Taros Chemicals and Amsterdam University Medical Centers, has been awarded with a budget of 2,4 million euros from the prestigious EUREKA- EUROSTARS innovation program.
A consortium comprising Grünenthal, Taros Chemicals and three research groups from the Institute for Neurosciences and Medicine (INM) of the Research Centre Jülich employed positron emission tomography (PET) as imaging method to investigate the interaction of a single drug with two specific targets…
Cardiovascular diseases are still one of the most frequent causes of death. Since the heart muscle cannot regenerate itself, the tissue is usually remodeled leading to impaired heart function in the long term. Many patients who have survived a heart attack suffer from cardiac insufficiency years later…
Taros EVP Youri R. Mesmoudi was interviewed in the current Issue of CHEManager´s Section Chemistry & Life Sciences on “From Idea to Product – the principle of an extended workbench accelerates innovation in chemistry”
Due to current situation with the spread of the Sars-CoV-2 (“Coronavirus”) we want to share with you the latest information on how Taros Chemicals have prepared for both, the protection of our employees and partners’ health and the uninterrupted continuation of our chemistry and discovery services to our clients…
